Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes

Cellular Microbiology

Volumn 13, Issue 6, 2011, Pages 836-845

  Sicard, Audrey ^a,f   Semblat, Jean Philippe ^a,f   Doerig, Caroline ^a,f   Hamelin, Romain ^a   Moniatte, Marc ^a   Dorin Semblat, Dominique ^a,f   Spicer, Julie A ^b   Srivastava, Anubhav ^c   Retzlaff, Silke ^d   Heussler, Volker ^d,e   Waters, Andrew P ^c   Doerig, Christian ^a,f  

^a EPFL   (Switzerland)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE 1;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROCYTE; HUMAN; HUMAN CELL; MEROZOITE; NONHUMAN; PATHOGENESIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT; SIGNAL TRANSDUCTION; TROPHOZOITE;

ANIMALS; ANTIMALARIALS; ERYTHROCYTES; HUMANS; INHIBITORY CONCENTRATION 50; MAP KINASE KINASE 1; P21-ACTIVATED KINASES; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; RODENTIA;

EID: 79955966556     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2011.01582.x     Document Type: Article

References (39)

1. Anamika, Srinivasan, N., and Krupa, A. (2005) A genomic perspective of protein kinases in Plasmodium falciparum. Proteins 58: 180-189.
2. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C.J., McLauchlan, H., etal. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315.
3. Baumeister, S., Winterberg, M., Duranton, C., Huber, S.M., Lang, F., Kirk, K., and Lingelbach, K. (2006) Evidence for the involvement of Plasmodium falciparum proteins in the formation of new permeability pathways in the erythrocyte membrane. Mol Microbiol 60: 493-504.
4. Blisnick, T., Morales Betoulle, M.E., Barale, J.C., Uzureau, P., Berry, L., Desroses, S., etal. (2000) Pfsbp1, a Maurer's cleft Plasmodium falciparum protein, is associated with the erythrocyte skeleton. Mol Biochem Parasitol 111: 107-121.
5. Brunet, A., Pages, G., and Pouyssegur, J. (1994) Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1). FEBS Lett 346: 299-303.
6. Chong, C., Tan, L., Lim, L., and Manser, E. (2001) The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity. J Biol Chem 276: 17347-17353.
7. Davis, R.J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252.
8. Deacon, S.W., Beeser, A., Fukui, J.A., Rennefahrt, U.E., Myers, C., Chernoff, J., and Peterson, J.R. (2008) An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol 15: 322-331.
9. DeSilva, D.R., Jones, E.A., Favata, M.F., Jaffee, B.D., Magolda, R.L., Trzaskos, J.M., and Scherle, P.A. (1998) Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J Immunol 160: 4175-4181.
10. Desjardins, R.E., Canfield, C.J., Haynes, J.D., and Chulay, J.D. (1979) Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710-718.
11. Dorin, D., Alano, P., Boccaccio, I., Ciceron, L., Doerig, C., Sulpice, R., etal. (1999) An atypical mitogen-activated protein kinase (MAPK) homologue expressed in gametocytes of the human malaria parasite Plasmodium falciparum. Identification of a MAPK signature. J Biol Chem 274: 29912-29920.
12. Dorin, D., Le Roch, K., Sallicandro, P., Alano, P., Parzy, D., Poullet, P., etal. (2001) Pfnek-1, a NIMA-related kinase from the human malaria parasite Plasmodium falciparum biochemical properties and possible involvement in MAPK regulation. Eur J Biochem 268: 2600-2608.
13. Dorin, D., Semblat, J.P., Poullet, P., Alano, P., Goldring, J.P., Whittle, C., etal. (2005) PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum. Mol Microbiol 55: 184-196.
14. Dorin-Semblat, D., Quashie, N., Halbert, J., Sicard, A., Doerig, C., Peat, E., etal. (2007) Functional characterization of both MAP kinases of the human malaria parasite Plasmodium falciparum by reverse genetics. Mol Microbiol 65: 1170-1180.
15. Dorin-Semblat, D., Sicard, A., Doerig, C., Ranford-Cartwright, L., and Doerig, C. (2008) Disruption of the PfPK7 gene impairs schizogony and sporogony in the human malaria parasite Plasmodium falciparum. Eukaryot Cell 7: 279-285.
16. Graewe, S., Retzlaff, S., Struck, N., Janse, C.J., and Heussler, V.T. (2009) Going live: a comparative analysis of the suitability of the RFP derivatives RedStar, mCherry and tdTomato for intravital and in vitro live imaging of Plasmodium parasites. Biotechnol J 4: 895-902.
17. Haldar, K., and Mohandas, N. (2007) Erythrocyte remodeling by malaria parasites. Curr Opin Hematol 14: 203-209.
18. Harrison, T., Samuel, B.U., Akompong, T., Hamm, H., Mohandas, N., Lomasney, J.W., and Haldar, K. (2003) Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 301: 1734-1736.
19. Heussler, V., Sturm, A., and Langsley, G. (2006) Regulation of host cell survival by intracellular Plasmodium and Theileria parasites. Parasitology 132: S49-S60.
20. Manno, S., Takakuwa, Y., and Mohandas, N. (2005) Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J Biol Chem 280: 7581-7587.
21. Ohren, J.F., Chen, H., Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., etal. (2004) Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat Struct Mol Biol 11: 1192-1197.
22. Park, E.R., Eblen, S.T., and Catling, A.D. (2007) MEK1 activation by PAK: a novel mechanism. Cell Signal 19: 1488-1496.
23. Parrini, M.C., Matsuda, M., and de Gunzburg, J. (2005) Spatiotemporal regulation of the Pak1 kinase. Biochem Soc Trans 33: 646-648.
24. Prudencio, M., Rodrigues, C.D., Hannus, M., Martin, C., Real, E., Goncalves, L.A., etal. (2008) Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection. PLoS Pathog 4: e1000201.
25. Raman, M., Chen, W., and Cobb, M.H. (2007) Differential regulation and properties of MAPKs. Oncogene 26: 3100-3112.
26. Ringrose, J.H., van Solinge, W.W., Mohammed, S., O'Flaherty, M.C., van Wijk, R., Heck, A.J., and Slijper, M. (2008) Highly efficient depletion strategy for the two most abundant erythrocyte soluble proteins improves proteome coverage dramatically. J Proteome Res 7: 3060-3063.
27. Rossomando, A.J., Dent, P., Sturgill, T.W., and Marshak, D.R. (1994) Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylation. Mol Cell Biol 14: 1594-1602.
28. Roux-Dalvai, F., Gonzalez de Peredo, A., Simo, C., Guerrier, L., Bouyssie, D., Zanella, A., etal. (2008) Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics 7: 2254-2269.
29. Sartori, M., Ceolotto, G., and Semplicini, A. (1999) MAPKinase and regulation of the sodium-proton exchanger in human red blood cell. Biochim Biophys Acta 1421: 140-148.
30. Sebolt-Leopold, J.S., and Herrera, R. (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4: 937-947.
31. Sharma, P., Veeranna, Sharma, M., Amin, N.D., Sihag, R.K., Grant, P., etal. (2002) Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J Biol Chem 277: 528-534.
32. Singh, A.P., Buscaglia, C.A., Wang, Q., Levay, A., Nussenzweig, D.R., Walker, J.R., etal. (2007) Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 131: 492-504.
33. Slack-Davis, J.K., Eblen, S.T., Zecevic, M., Boerner, S.A., Tarcsafalvi, A., Diaz, H.B., etal. (2003) PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J Cell Biol 162: 281-291.
34. Spillman, M.A., Lacy, J., Murphy, S.K., Whitaker, R.S., Grace, L., Teaberry, V., etal. (2007) Regulation of the metastasis suppressor gene MKK4 in ovarian cancer. Gynecol Oncol 105: 312-320.
35. Squires, M.S., Nixon, P.M., and Cook, S.J. (2002) Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem J 366: 673-680.
36. Viaud, J., and Peterson, J.R. (2009) An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently. Mol Cancer Ther 8: 2559-2565.
37. Ward, P., Equinet, L., Packer, J., and Doerig, C. (2004) Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. BMC Genomics 5: 79.
38. Xu, B., Wilsbacher, J.L., Collisson, T., and Cobb, M.H. (1999) The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo. J Biol Chem 274: 34029-34035.
39. Zhang, J., Yang, P.L., and Gray, N.S. (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9: 28-39.